Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The genomic landscape of juvenile myelomonocytic leukemia
Elliot Stieglitz, Amaro Taylor‐Weiner, Tiffany Chang, et al.
Nature Genetics (2015) Vol. 47, Iss. 11, pp. 1326-1333
Open Access | Times Cited: 263

Showing 1-25 of 263 citing articles:

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury, Éric Solary, Oussama Abla, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1703-1719
Open Access | Times Cited: 2584
Clonal evolution of glioblastoma under therapy
Jiguang Wang, Emanuela Cazzato, Erik Ladewig, et al.
Nature Genetics (2016) Vol. 48, Iss. 7, pp. 768-776
Open Access | Times Cited: 675
The NF1 somatic mutational landscape in sporadic human cancers
Charlotte Philpott, Hannah Tovell, Ian M. Frayling, et al.
Human Genomics (2017) Vol. 11, Iss. 1
Open Access | Times Cited: 261
Splicing-factor alterations in cancers
Olga Anczuków, Adrian R. Krainer
RNA (2016) Vol. 22, Iss. 9, pp. 1285-1301
Open Access | Times Cited: 256
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes
K. Martin Kortüm, K. Elias, Nur Hafzan Md Hanafiah, et al.
Blood (2016) Vol. 128, Iss. 9, pp. 1226-1233
Open Access | Times Cited: 218
The genomic landscape of pediatric myelodysplastic syndromes
Jason R. Schwartz, Jing Ma, Tamara Lamprecht, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 171
DNMT3A in Leukemia
Lorenzo Brunetti, Michael C. Gundry, Margaret A. Goodell
Cold Spring Harbor Perspectives in Medicine (2016) Vol. 7, Iss. 2, pp. a030320-a030320
Open Access | Times Cited: 170
Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A review
Kavanya Feustel, Gerald S. Falchook
Journal of Immunotherapy and Precision Oncology (2022) Vol. 5, Iss. 3, pp. 58-67
Open Access | Times Cited: 79
RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives
Dana Alawieh, Leila Cysique-Foinlan, Christophe Willekens, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse
Jason E. Farrar, Heather L. Schuback, Rhonda E. Ries, et al.
Cancer Research (2016) Vol. 76, Iss. 8, pp. 2197-2205
Open Access | Times Cited: 154
Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
Zhimin Gu, Yuxuan Liu, Feng Cai, et al.
Cancer Discovery (2019) Vol. 9, Iss. 9, pp. 1228-1247
Open Access | Times Cited: 141
Juvenile myelomonocytic leukemia: who’s the driver at the wheel?
Charlotte M. Niemeyer, Christian Flotho
Blood (2019) Vol. 133, Iss. 10, pp. 1060-1070
Open Access | Times Cited: 140
Advances in germline predisposition to acute leukaemias and myeloid neoplasms
Jeffery M. Klco, Charles G. Mullighan
Nature reviews. Cancer (2020) Vol. 21, Iss. 2, pp. 122-137
Open Access | Times Cited: 123
How I treat chronic myelomonocytic leukemia
Éric Solary, Raphaël Itzykson
Blood (2017) Vol. 130, Iss. 2, pp. 126-136
Open Access | Times Cited: 106
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
Daniel B. Lipka, Tania Witte, Réka Tóth, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 105
DeTiN: overcoming tumor-in-normal contamination
Amaro Taylor‐Weiner, Chip Stewart, Thomas J. Giordano, et al.
Nature Methods (2018) Vol. 15, Iss. 7, pp. 531-534
Open Access | Times Cited: 96
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML
Akihide Yoshimi, Maria E. Balasis, Alexis Vedder, et al.
Blood (2017) Vol. 130, Iss. 4, pp. 397-407
Open Access | Times Cited: 93
Integrated molecular profiling of juvenile myelomonocytic leukemia
Norihiro Murakami, Yusuke Okuno, Kenichi Yoshida, et al.
Blood (2018) Vol. 131, Iss. 14, pp. 1576-1586
Open Access | Times Cited: 91
Myelodysplastic and myeloproliferative disorders of childhood
Henrik Hasle
Hematology (2016) Vol. 2016, Iss. 1, pp. 598-604
Open Access | Times Cited: 87
Metabolic dependencies and vulnerabilities in leukemia
Marissa Rashkovan, Adolfo A. Ferrando
Genes & Development (2019) Vol. 33, Iss. 21-22, pp. 1460-1474
Open Access | Times Cited: 81
MDS overlap disorders and diagnostic boundaries
Tiffany Tanaka, Rafael Bejar
Blood (2019) Vol. 133, Iss. 10, pp. 1086-1095
Open Access | Times Cited: 80
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis
Haijiao Zhang, Beth Wilmot, Daniel Bottomly, et al.
Blood (2019) Vol. 134, Iss. 11, pp. 867-879
Open Access | Times Cited: 76
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
Ryan M. Carr, Denis Vorobyev, Terra L. Lasho, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 67
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus
Peter de Blank, Andrea M. Gross, Srivandana Akshintala, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 11, pp. 1845-1856
Open Access | Times Cited: 60
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia
Elliot Stieglitz, Tali Mazor, Adam B. Olshen, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top